Small for gestational age (SGA) is associated with an increased risk of non-alcoholic fatty liver disease (NAFLD). Our aim was to investigate the correlation of birthweight with the severity of liver damage in a large cohort of children with NAFLD.
INTRODUCTION
Non-alcoholic fatty liver disease (NAFLD) is the most frequent chronic liver disease worldwide both in adults and children ( 1 ) , dramatically rising in concert with the epidemics of obesity and type 2 diabetes (T2DM), the major features of metabolic syndrome ( 2, 3 ) . NAFLD includes two distinct phenotypes with different histologic features and prognoses: non-alcoholic fatty liver (NAFL) or simple steatosis and non-alcoholic steatohepatitis (NASH); the latter is featured by hepatocellular injury, infl ammation, and various degrees of fi brosis, up to advanced fi brosis and cirrhosis ( 4 ) .
NAFLD is a multifactorial disease, with both genetic and environmental risk factors, and has a substantial inter-patient variability in terms of severity and rate of progression (5) (6) (7) . In adults, as observed by Ekstedt et al. ( 8 ) , patients with NAFLD have a lower survival compared with the general population, related to cardiovascular and liver diseases; however, the fi brosis stage, rather than NAFLD Activity Score (NAS), is the best predictor of liver-related mortality. On the contrary, limited longitudinal studies are available in the pediatric population ( 9 ) .
In the United States, the histologically proven prevalence of NAFLD in children in the (as revealed at autopsy aft er accidents) ranges from 9.6% in normal-weight individuals up to 38% in obese ones ( 10 ) , but can be higher in selected tertiary centers. In the pediatric setting, intrauterine environment may have a pivotal role in the onset and progression of NAFLD ( 5, 11 ) . Th e term small for gestational age (SGA) applies to newborns with an actual birthweight below the 10th weight percentile for age in gestational weeks ( 12 ) . During the fi rst years of life, most children born SGA (70-90%) exhibit the phenomenon of "catch-up growth, " which is associated to an increased risk of metabolic alterations and T2DM later in life ( 13, 14 ) , but whether this is due to environmental or genetic causes is still controversial. According to the "thrift y phenotype" hypothesis, a hostile intrauterine environment may induce the activation of endocrine mechanisms and gene reprogramming, leading to reduced insulin secretion and increased insulin resistance ( 15 ) . On the contrary, the "fetal insulin hypothesis" suggests that alterations in insulin sensitivity and secretion in newborns with low birthweight are genetically ( 16 ) . In any case, at birth, when nutrient availability is higher, this "greedy" metabolism may cause fast weight gain and fat accumulation predisposing to metabolic syndrome and NAFLD in adulthood and increasing the risk of cardiovascular mortality ( 5, 9, 17 ) .
A recent longitudinal study in a population-based group of Finnish adults identifi ed SGA as an independent childhood predictor of adult fatty liver, along with high insulin and high body mass index (BMI). However, the impact of birthweight on the histologic features of liver damage remains incompletely characterized. In the same study, prediction of adult fatty liver was enhanced by taking into account genetic variants in patatin-like phospholipase domain-containing protein 3 ( PNPLA3 ) gene ( 18 ) . Mutated PNPLA3 I148M variant is attached on the surface of lipid droplets reducing triglyceride breakdown leading to lipid retention in the hepatocyte lipid droplet ( 19 ) . Th e major role of 148M mutant PNPLA3 in the development and progression of pediatric NAFLD and NASH is fully established by several pieces of evidence ( 3, 5, 6 ) .
Th e present study is undertaken to further investigate the relative role of metabolic abnormalities, birthweight, and PNPLA3 I148M gene variant in predicting the main histological features of liver damage in a large cohort of Italian children with biopsyproven NAFLD.
METHODS

Study population
We studied 288 Caucasian Italian children with biopsy-proven NAFLD, consecutively enrolled in the Liver Unit, "Bambino Gesù" Children's Hospital, Rome, Italy, from June 2001 to December 2015.
Aft er careful exclusion of other causes of liver diseases and secondary causes of hepatic steatosis (i.e., viral liver disease, autoimmune hepatitis, Wilson's disease, α -1-antitrypsin defi ciency, celiac disease, alcohol consumption, and use of drugs known to induce fatty liver), patients attended a research clinic visit and underwent standardized history, physical, and anthropometric exam, laboratory tests, and liver ultrasound. Liver biopsy was performed: (i) in all children with ultrasound evidence of liver steatosis and alanine aminotransferase elevation >6 months ( 20 ) and (ii) in all children with ultrasound evidence of liver steatosis and elevated BMI, hypertriglyceridemia, independent of alanine aminotransferase elevation, because this parameter may not be altered in pediatric NASH ( 21 ) .
Medical history and anthropometric data at birth were collected from their medical records and hospital charts. Gestational age data expressed in weeks. SGA and large for gestational age (LGA) were defi ned as birthweight at 10th percentile and >90th percentile for gestational age, respectively. Birthweights between the 10th and 90th percentiles were defi ned as appropriate for gestational age (AGA). Italian specifi c growth charts ( 22 ) were used to defi ne the three diff erent categories of birthweight corrected for gestational age and sex ( 23 ) .
Weight was measured by a conventional scale with a precision of 100 g and height was measured by a Harpenden stadiometer with a precision of 1 mm. BMI was expressed in kg m −2 . BMI s.d, scores ( Z -scores) were calculated, according to population-specifi c reference data ( 24 ) . Waist circumference was measured with a tape to the nearest 0.5 cm measure, at the narrowest circumference between the lower costal margin and the iliac crest in standing position.
Th e study was approved by the Institutional Review Board of the "Bambino Gesù" Children's Hospital, Rome, Italy. Informed consent was obtained from each patient and guardian.
Laboratory tests
Blood sampling for determination of all circulating substrates, hormones, and infl ammatory markers was performed 2 days before liver biopsy, aft er an overnight fast. Laboratory tests by automated commercial methods included: alanine aminotransferase, aspartate aminotransferase, and gamma-glutamyltransferase, high-density lipoprotein-cholesterol, low-density lipoproteincholesterol, total cholesterol, triglycerides, and uric acid.
All patients underwent an oral glucose tolerance test (1.75 g kg −1 , maximum 75 g) with glucose and insulin assessments at time 0, 30, 60, 90 and 120 min. Blood glucose (BG) was measured by the glucose oxidase technique (Cobas Integra; Roche, Basel, Switzerland). Insulin was measured by chemiluminescence on ADVIA Centaur analyzer (Siemens Healthcare Diagnostics Inc, Tarrytown, NY, USA). ( 25, 26 ) .
Glucose tolerance was defi ned according to the American Diabetes Association criteria ( 27 ) : BG <100 mg dl −1 is considered normal glucose tolerance, BG>100 and <125 mg dl −1 are considered impaired fasting glucose, and BG ≥126 mg dl −1 is considered T2DM. Th e oral glucose tolerance test (BG at 120') was used to further categorize all study subjects into normal glucose tolerance (BG<140 mg dl −1 ), impaired glucose tolerance (BG>140 and <199 mg dl −1 ), and T2DM (BG≥200 mg dl −1 ). Th e circulating levels of tumor necrosis factor (TNF)-α , interleukin (IL)-1β , and IL-6 were measured according to the manufacturer's recommendations by commercially available ELISA kits (BioVendor, Heidelberg, Germany).
Blood pressure measurement
All patients underwent a 24 h ambulatory blood pressure monitoring (Spacelab 90207, Spacelab Inc., Redmond, WA, equipped with an adequate cuff size). Diagnosis of hypertension was made according to tables of oscillometric mean ambulatory blood pressure monitoring values for healthy children adjusted for gender and height, systolic or diastolic blood pressure >95 th percentile for age and sex ( 28, 29 ) .
Genotyping
DNA was extracted from peripheral blood. Genotyping for PNPLA3 I148M gene variant (rs738409) was carried out using the TaqMan SNP genotyping allelic discrimination method (Applied Biosystems, Foster City, CA). Commercial genotyping assays were available for the following rs738409 (cat. C_7241_10). A custom assay was created by Applied Biosystem for rs12979860. Th e genotyping call was done with SDS soft ware v.1.3.0 (ABI Prism 7500, Foster City, CA).
Liver histology
Liver biopsy was performed aft er an overnight fast, using an automatic core biopsy 18 gauge needle (Biopince, Amedic, Sweden) under general anesthesia and ultrasound guidance. An experienced liver pathologist reviewed all liver biopsy specimens to confi rm the diagnosis and performed the following scoring.
Biopsy samples were evaluated adequate if >20 mm long and/or containing more than 5 complete portal tracts ( 30 ) . NAFLD histology was assessed according to the Kleiner fi brosis stage (0=none, 1a=mild perisinusoidal, 1b=moderate perisinusoidal, 1c=portal/ periportal, 2=zone 3 and portal/periportal, 3=bridging fi brosis, and 4=cirrhosis) ( 31, 32 ) . Ubiquitin immunohistochemistry was used to identify Mallory-Denk bodies. NASH was defi ned as the presence of combined hepatic steatosis, infl ammation, and ballooning according to the American Association for the Study of Liver Diseases guidelines ( 33 ) and the patients were categorised as NAFL or NASH.
In addition, children were classifi ed according to their histologic characteristics into three groups: type 1 NAFLD (all patient with steatosis, ballooning, and/or perisinusoidal fi brosis but an absence of portal infl ammation or periportal fi brosis), type 2 NAFLD (steatosis with portal infl ammation and/or periportal fi brosis without ballooning or perisinusoidal fi brosis), and overlap type (all patients with features of both type 1 and 2).
Statistical analysis
Data are reported as mean±s.d. for normal continuous variables, median (25th-75th percentiles) for not normally distributed continuous variables, and frequencies for categorical variables. Diff erences between groups were evaluated with the t -test for variables normally distributed or with the Mann-Whitney test if variables were not normally distributed. For categorical variable, diff erences between groups were assessed with the χ 2 -test or with the χ 2 -test for trend as appropriate. Th e association between the birthweight and histological features or infl ammatory markers were assessed by the Spearman's correlation analysis. Univariate and multivariable logistic regression analysis were performed to assess predictors of severe steatosis (≥66%), NAS≥5, portal infl ammation (≥1), and fi brosis (F≥2). A P -value<0.05 was considered statistically signifi cant. All analyses were performed using MedCalc Soft ware, version 12.7 (Ostend, Belgium; 2013).
RESULTS
Two hundred and eighty-eight consecutive overweight/obese children (133 males and 155 females), age range 6-17 years, were included in our study. Aft er collection of medical history and anthropometric data at birth, obtained from both patients and medical records, SGA, AGA, and LGA profi les were defi ned and the study subjects subdivided accordingly. Table 1 shows the anthropometric and biochemical variables of the cohort as a whole and subdivided according to liver histology (NAFL or NASH). None of the patients had T2DM, but 20% had an impaired glucose tolerance according to oral glucose tolerance test. NASH was diagnosed in two-third of the patients and significant (F2/F3) fi brosis in one-third. No patient had cirrhosis. Children with NASH had more raised values of systolic blood pressure, fasting glucose, insulin, and HOMA-IR compared with NAFL. Th e prevalence of SGA in NASH group was 1.5-fold higher compared with the NAFL, whereas the prevalence of AGA and LGA were similar in the two groups. Not surprisingly, the presence of the PNPLA3-GG variant was fi vefold higher in children with NASH ( Table 1 ).
In the whole NAFLD population, 35 patients were born SGA (12.2%), 181 were AGA (62.8%), and 72 were LGA (25%) ( Table 2 ). In LGA children, BMI, waist circumference, and BG were increased ( P <0.001 and P =0.03, respectively) compared with both AGA and SGA. Th e prevalence of impaired glucose tolerance was fi vefold higher in LGA children compared with AGA, whereas all SGA were normal glucose tolerance. PNPLA3 variants were not signifi cantly diff erent across the three groups. To examine the impact of birthweight on liver damage in this pediatric cohort, we analyzed the histological features according to being born SGA, AGA, or LGA ( Table 3 ) . NAFLD patient born SGA had a higher prevalence of severe steatosis and severe portal infl ammation compared with the AGA and LGA groups ( P =0.021 and P =0.002, respectively), whereas lobular infl ammation and ballooning were similar in all groups. A comparable trend was also observed for portal infl ammation, with the highest degrees in children born SGA. Signifi cant fi brosis (F2-F3) was more common in the AGA group, which obviously was the largest group of children ( Table 3 ) .
Th e distribution of the degrees of steatosis and portal infl ammation in NAFLD children according to their weight at birth is shown in Figure 1 . Strikingly, severe steatosis (>66%) was decreasing from SGA to AGA and LGA, whereas the prevalence of moderate steatosis (33-66%) was similar in all groups.
Interestingly, the classifi cation of our children into three "NAFLD types" ( Table 4 ) showed that in the SGA group the most prevalent histological form of NASH was the "Overlap type" compared with "Type 1" and "Type2": 85.7% vs. 5.7% and 8.5%, respectively ( P =0.01).
Th e Spearman's correlation between the birth size of NAFLD children and their histological parameters confi rmed the inverse association between birthweight, degrees of steatosis ( ρ =−0.19; 95% confi dence interval (CI) −0.30, −0.08; P =0.001) and of portal infl ammation ( ρ =−0.20; 95% CI −0.31, −0.09; P <0.001). Weight at birth was also inversely correlated with the severe fi brosis ( ρ =−0.177; 95% CI −0.29, −0.06; P =0.003). Th e presence of signifi cant fi brosis (F2/F3) was inversely related with birthweight and directly with insulin levels and blood pressure. Th e PNPLA3-CC wild-type genotype however was the strongest independent predictor of the absence of signifi cant fi brosis both at univariate and multivariable analysis ( Supplementary  Table 2 ) .
A NAS≥5 was associated with elevated liver function tests, fasting glucose and insulin levels, raised HOMA-IR and blood pressure, SGA, and PNPLA3 genotype ( Table 6 ). At multivariate analysis, being born SGA increased almost threefold the likelihood of NAS≥5 independently of insulin resistance and PNPLA3 genotype, but this was most likely to be due to its major impact on steatosis.
In order to provide an explanation for the worse histological profi le of NAFLD children born SGA compared with the AGA At univariate analysis, severe steatosis was associated with birthweight, raised aminotransferases, increased glucose and insulin levels, higher HOMA-IR, higher prevalence of SGA, and lower prevalence of the PNPLA3-CC genotype. At multivariable regression analysis, SGA at birth increased fourfold the likelihood of severe steatosis (odds ratio (OR) 4.0, 95% CI 1.43-10.9, P =0.008), independently of HOMA-IR and PNPLA3 genotype ( Table 5 ) .
Th e presence of portal infl ammation was associated with waist circumference, birthweight, gamma-glutamyltransferase, and total cholesterol at univariate analysis, but the association with SGA was not confi rmed due to a type II error, as only two patients had no portal infl ammation. PNPLA3 genotype did not aff ect the presence of portal infl ammation ( Supplementary Table 1 ) . LGA, large gestational age; S, steatosis; SGA, small gestational age. 
DISCUSSION
Th e major fi nding of the present study is the clear association between the severity of steatosis and SGA in children with NAFLD, independent of and in addition to other powerful risk factors such as insulin resistance and PNPLA3 I148M gene variant. We had previously shown the association of pediatric NAFLD with SGA ( 35 ) . However, the current study further extends our and LGA, we assessed the plasma levels of TNF-α , IL-6, and IL-1β , considered between the most common markers of systemic infl ammation in children with NASH ( 34 ) . ALT, alanine aminotransferase; BMI, body mass index; CI, confi dence interval; DBP, diastolic blood pressure; GGT, gamma-glutamyl aminotransferase; HDL-cholesterol, high-density lipoprotein cholesterol; HOMA-IR, homeostasis model of assessment-insulin resistance index; OR, odds ratio; PNPLA3 , patatin-like phospholipase domaincontaining 3; SBP, systolic blood pressure; SGA, small gestational age.
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knowledge pointing out that, in children with NAFLD, SGA is also a risk factor for a more severe fat accumulation early in life that could eventually translate in a higher rate of hepatic and extrahepatic complications during adulthood. Recent epidemiological studies have related birthweight and NAFLD in the general population. In Finnish adults, a signifi cant association between adulthood liver fat score and birthweight has been observed in women ( 19 ) . In the Cardiovascular Risk in Young Finns Study ( 36 ) , low birthweight was a childhood predictors of adult NAFLD at follow-up of 31 years, in addition to other well-known variables. Th e odds ratio for SGA was 1.71, higher than BMI (OR 1.30), fasting insulin levels (OR 1.25), and the common PNPLA3 I148M variant (OR 1.63). However, none of the above-mentioned studies examined liver histology. Here we demonstrate that being born SGA provides an additional risk on the amount of fat accumulation in the liver of children with biopsy-proven NAFLD.
Traditionally, simple steatosis does not harbinger an increased risk of disease progression, but a study with paired biopsies recently challenged this notion ( 37 ) . Aft er a median interval of 6.6 years, 27/108 (22%) patients with baseline NAFL reached stage 3 fi brosis at follow-up biopsy. Among the patients with NAFL, 80% of those having fi brosis progression were diabetic at the follow-up liver biopsy. In our study cohort, the young age reduces the likelihood of fi brosis, which takes decades to develops, but it is conceivable that an increased liver fat in NAFLD subjects born SGA could be translated into an increased risk of disease progression later in life. Further, the excess fat could also boost the well-documented risk of developing T2DM in adulthood ( 10, 38 ) , an additional negative prognostic factor for liver-related outcomes. Accordingly, the incidence rate of increases progressively according to the ultrasonographic severity of NAFLD at baseline (normal: 7.0%, mild: 9.8%, moderate-to-severe: 17.8%, P <0.001) aft er adjusting for multiple confounders ( 39 ) .
Causative mechanisms linking the severity of liver damage in NAFLD with gestational age at birth are still under investigation. Rapid weight catch-up growth, a major risk factor for later development of insulin-related complications, can be implicated in the presence and severity of NAFLD in both children and adults ( 40 ). Th is study has two main limitations. Th e fi rst is the diffi culty of indicating a true prevalence of NASH in the SGA group, because it was not possible to have a control group of non-obese SGA children without NAFL/NASH. Th e second is due to fact that most of children had NASH, because the study has been conducted in a tertiary center with a careful selection before liver biopsy.
In conclusion, SGA is an important risk factor for the severity of steatosis in pediatric NAFLD, independent of and in addition to other powerful risk factors such as insulin resistance, and PNPLA3 gene variants. Careful monitoring of SGA children with NAFLD may be considered to avoid hepatic and extrahepatic complications during adulthood.
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Study Highlights
WHAT IS CURRENT KNOWLEDGE
✓ Several studies have showed that children born Small gestational age (SGA) have an increased risk to develop non-alcoholic fatty liver disease (NAFLD) and other metabolic anomalies such as insulin resistance.
WHAT IS NEW HERE
✓ The major fi nding of our study is the clear association of small birthweight with the severity of steatosis in pediatric NAFLD, independent of and in addition to other powerful risk factors such as insulin resistance and PNPLA3 gene variants.
However, in the Finnish study ( 36 ) , low birthweight was associated with adult fatty liver even when adjusted with childhood BMI and insulin levels, suggesting that this association cannot be simply explained by catch-up growth occurring in children born SGA. Similarly, in our study, the link between SGA and severe steatosis in NAFLD was independent and, in addition to insulin resistance, refl ecting a more profound alteration possibly related the adverse intrauterine environment. Studies in adults and children born SGA indicate that insulin resistance is the earliest component associated with low birthweight, irrespective of confounding factors, including obesity and a family history of T2DM (38) (39) (40) . Nutrition in an adverse intrauterine environment during fetal life can be able to trigger a metabolic adaptation by epigenetic regulation of gene expression and thereby permanently sets functional capacity, metabolic competence, and responses to the later environment that favour NAFLD ( 41 ) . Furthermore, liver growth itself may be impaired and reduced as part of the adaptive response to a poor fetal substrate supply ( 41 ) .
Th e degree of portal infl ammation is the other histological feature associated with SGA in our cohort of NAFLD children, but this study is underpowered to detect and independent eff ect of SGA, due to the low number of children without portal infl ammation. In fact, the diff erent distribution could be the merely consequence of the diff erent number of patients into the three groups. However, the most prevalent presence of Type 1 patter in the LGA group could refl ect the highest prevalence of mild fi brosis in this group compared with the other two groups. By contrast, the SGA group seems to fully refl ect the most common patter already published in pediatric Rome population where most of our children had portal injury placing them as either NAFLD type 2 or overlap of type 1 and 2 NAFLD ( 42 ). In the SGA group, only 2 children had no portal infl ammation compared with 16 children and 18 children in the AGA and LGA groups, respectively. Moreover, in this study, the association of a high NAS with SGA is most likely to be mediated by the degree of steatosis, but a primary role of SGA in the onset of portal infl ammation cannot be completely ruled out and should be detected in larger populations. Most importantly, longitudinal studies with paired liver biopsies are needed to assess whether a higher degree of steatosis and portal infl ammation in NAFLD children born with SGA will prospectively translate into a more rapid progression to fi brosis and cirrhosis. Th is inference on the possible anticipated evolution of fi brosis in NASH children born SGA is also sustained by the confi rm that also in this cohort of children genetic variation at PNPLA3 confers a markedly increased risk of increasingly severe histological features of NAFLD.
In the last years, increased circulating levels of IL-6 and TNF-α were found increased in cord blood of SGA children compared with AGA ( 43 ) . We previously reported that fatty liver in obese children is characterized by increased production of pro-infl ammatory cytokines, such as IL-1β , IL-6, TNF-α , secondary to stimulation of the endotoxin-induced Toll-like receptor 4 signaling, and strongly associated with the severity of NASH-related liver damage ( 34, 44, 45 ) . In our cohort, we found a negative correlation between TNF-α , IL-6, and IL-1 β circulating levels and birthweight. Th e signifi cant increase of the level soft these cytokines in NAFLD
